Matricellular proteins are extracellular matrix proteins that modulate cell-matrix interactions and cell function, and do not seem to have a direct structural role. The family includes tenascin-C (TN-C), tenascin-X (TN-X), osteonectin, osteopontin, thrombospondin-1 (TSP1) and thrombospondin-2 (TSP2). Expression of matricellular proteins is high during embryogenesis, but almost absent during normal postnatal life. Interestingly, it re-appears in response to injury. Left ventricular remodeling is a complicated process that occurs in the stressed heart, and is still not completely understood. Several members of the matricellular protein family, like tenascin-C, osteopontin, and osteonectin are up-regulated after cardiac injury. Therefore, this group of proteins may have crucial functions in the heart coping with stress. This review will focus on the expression, regulation and function of these matricellular proteins, and will discuss the crucial functions that these proteins might exert during remodeling of the stressed heart.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.cardiores.2004.06.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stage-Dependent Fibrotic Gene Profiling of WISP1-Mediated Fibrogenesis in Human Fibroblasts.
Cells
December 2024
Biotherapeutics Enabling Biology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46225, USA.
Idiopathic pulmonary fibrosis (IPF) is the most common interstitial lung disease with unknown etiology, characterized by chronic inflammation and tissue scarring. Although, Pirfenidone and Nintedanib slow the disease progression, no currently available drugs or therapeutic interventions address the underlying cause, highlighting the unmet medical need. A matricellular protein, Wnt-1-induced secreted protein 1 (WISP1), also referred to as CCN4 (cellular communication network factor 4), is a secreted multi-modular protein implicated in multi-organ fibrosis.
View Article and Find Full Text PDFSmooth muscle cell-specific CD47 deletion suppresses atherosclerosis.
Life Sci
December 2024
Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA. Electronic address:
Background: Recent smooth muscle cell (SMC)-lineage tracing and single-cell RNA sequencing (scRNA-seq) experiments revealed a significant role of SMC-derived cells in atherosclerosis development. Further, thrombospondin-1 (TSP1), a matricellular protein, and activation of its receptor cluster of differentiation (CD) 47 have been linked with atherosclerosis. However, the role of vascular SMC TSP1-CD47 signaling in regulating VSMC phenotype and atherogenesis remains unknown.
View Article and Find Full Text PDFThe roles of periostin derived from cancer-associated fibroblasts in tumor progression and treatment response.
Cancer Metastasis Rev
November 2024
Universidade Federal de Alagoas, Campus Arapiraca, Centro de Ciências Médicas, Av. Manoel Severino Barbosa, Bom Sucesso, Arapiraca, AL, CEP 57309-005, Brazil.
Periostin (POSTN), a matricellular protein predominantly secreted by cancer-associated fibroblasts (CAFs), has emerged as a key regulator of cancer progression and therapy response. This review provides an overview of recent findings regarding the diverse roles of periostin in cancer therapy and its potential as a therapeutic target. Studies have elucidated periostin's involvement in tumorigenesis, including tumor growth, metastasis, chemotherapy resistance, and modulation of the tumor microenvironment (TME).
View Article and Find Full Text PDFThe Origins of Engineered Biomaterials: NSF-Funded, University of Washington Engineered Biomaterials (UWEB).
Bioengineering (Basel)
November 2024
Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.
The University of Washington Engineered Biomaterials (UWEB) Engineering Research Center (ERC) was funded from 1996 to 2007 by the U.S. National Science Foundation.
View Article and Find Full Text PDFThe oncogenic functions of SPARCL1 in bladder cancer.
J Cell Mol Med
November 2024
Department of Urology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Article Synopsis
- SPARCL1, a protein from the SPARC family, is under-researched in the context of bladder cancer (BCa), leading to an exploration of its expression patterns and correlations with clinical features.
- The study found that higher levels of SPARCL1 in BCa are associated with more advanced stages of the disease and poorer patient outcomes, while in vitro tests showed that increased SPARCL1 expression can inhibit tumor cell activities.
- Moreover, SPARCL1 is linked to immune features like tumor mutation burden (TMB) and activation, suggesting a role in macrophage behavior and positioning it as a potential prognostic biomarker for BCa.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!